Co-ordinate variations in methylmalonyl-CoA mutase and methionine synthase, and the cobalamin cofactors in human glioma cells during nitrous oxide exposure and the subsequent recovery phase.
We investigated the co-ordinate variations of the two cobalamin (Cbl)-dependent enzymes, methionine synthase (MS) and methylmalonyl-CoA mutase (MCM), and measured the levels of their respective cofactors, methylcobalamin (CH3Cbl) and adenosylcobalamin (AdoCbl) in cultured human glioma cells during nitrous oxide exposure and during a subsequent recovery period of culture in a nitrous oxide-free atmosphere (air). In agreement with published data, MS as the primary target of nitrous oxide was inactivated rapidly (initial rate of 0.06 h(-1)), followed by reduction of CH3Cbl (to <20%). Both enzyme activity and cofactor levels recovered rapidly when the cells were subsequently cultured in air, but the recovery was completely blocked by the protein-synthesis inhibitor, cycloheximide. During MS inactivation, there was a reduction of cellular AdoCbl and holo-MCM activity (measured in the absence of exogenous AdoCbl) to about 50% of pre-treatment levels. When the cells were transferred to air, both AdoCbl and holo-MCM activity recovered, albeit more slowly than the MS system. Notably, the regain of the holo-MCM and AdoCbl was enhanced rather than inhibited by cycloheximide. These findings confirm irreversible damage of MS by nitrous oxide; hence, synthesis of the enzyme is required to restore its activity. In contrast, restoration of holo-MCM activity is only dependent on repletion of the AdoCbl cofactor. We also observed a synchronous fluctuation in AdoCbl and the much larger hydroxycobalamin pool during the inactivation and recovery phase, suggesting that the loss and repletion of AdoCbl reflect changes in intracellular Cbl homoeostasis. Our data demonstrate that the nitrous oxide-induced changes in MS and CH3Cbl are associated with reversible changes in both MCM holoactivity and the AdoCbl level, suggesting co-ordinate distribution of Cbl cofactors during depletion and repletion.
Riedel
B
B
Department of Pharmacology, University of Bergen, Armauer Hansens hus, N-5021 Bergen, Norway. bettina.riedel@farm.uib.no
Fiskerstrand
T
T
Refsum
H
H
Ueland
P M
PM
D013766:5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase / Q000032:analysis / Q000187:drug effects*; D000332:Aerobiosis; D018685:Anesthetics, Inhalation / Q000494:pharmacology; D003038:Cobamides / Q000032:analysis*; D005260:Female; D005910:Glioma; D006801:Humans; D008765:Methylmalonyl-CoA Mutase / Q000032:analysis / Q000187:drug effects*; D009417:Nerve Tissue / Q000187:drug effects; D009609:Nitrous Oxide / Q000494:pharmacology*; D010084:Oxidation-Reduction; D014407:Tumor Cells, Cultured; D014805:Vitamin B 12 / Q000031:analogs & derivatives* / Q000032:analysis
D018685:Anesthetics, Inhalation; D003038:Cobamides; C019476:mecobalamin; D013766:5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; D008765:Methylmalonyl-CoA Mutase; C000913:cobamamide; D009609:Nitrous Oxide; D014805:Vitamin B 12